Insider sale
RETINALGENIX TECHNOLOGIES INC.
$45.5K
10.20K shares
What this filing means
BAYERN STEVEN plans to sell 10.20K shares of RETINALGENIX TECHNOLOGIES INC. valued at approximately $45.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/7/2023ACC: 0001959173-23-004573
10.20K
Shares to sell
$45.5K
Approx. market value
100K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Warrant Exercise
Cash/ check
3/26/2015
100KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/26/2015 | Warrant Exercise Cash/ check | 100K | — |
| Total | 100K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
200.00
Market value
$600.00
9/11/2023
Planned — Approximate Date
OTCPlanned
Units to sell
10K
Market value
$44.9K
11/7/2023
Total
Units
10.20K
Value
$45.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/11/2023 | 200.00 | $600.00 | — | Completed |
| Planned — Approximate Date | ||||
11/7/2023 | 10K | $44.9K | OTC | Planned |
| Total | 10.20K | $45.5K | ||